Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$18.34 USD
-0.41 (-2.19%)
Updated Dec 20, 2024 03:59 PM ET
After-Market: $18.35 +0.01 (0.05%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/26/2025
Time: -- |
12/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, Fulgent Genetics (FLGT) reported earnings of $0.31 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive earnings surprise of 263.16%. Look out for FLGT's next earnings release expected on February 26, 2025. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year decrease of 142.86%.
Earnings History
Price & Consensus
Zacks News for FLGT
All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy
FLGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for November 22nd
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates
TruBridge (TBRG) Reports Q3 Loss, Tops Revenue Estimates
FLGT FAQs
Fulgent Genetics, Inc. (FLGT) has announced they will report their next quarter earnings on February 26, 2025. For the next earning release, we expect the company to report earnings of $-0.12 per share, reflecting a year-over-year decrease of -142.86%.
Fulgent Genetics, Inc. has announced they will report their previous quarter earnings after the close of the market on February 26, 2025.
The Zacks Consensus Estimate for Fulgent Genetics, Inc. (FLGT) for the quarter ending December 2024 is $-0.12 a share. We expect Fulgent Genetics, Inc. (FLGT) to report earnings in line with the consensus estimate of $-0.12 per share
In the earnings report for the quarter ending in June 2024, Fulgent Genetics, Inc. (FLGT) announced earnings of $0.15 per share versus the Zacks Consensus Estimate of $-0.31 per share, representing a surprise of -148.39%.